» Authors » I Maruyama

I Maruyama

Explore the profile of I Maruyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 339
Citations 2766
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshida H, Hasegawa H, Katsuta N, Maruyama I, Sirono S, Minami M, et al.
Sci Adv . 2018 Dec; 4(12):eaau0872. PMID: 30525103
Spherical Fe-oxide concretions on Earth, especially in Utah, USA, have been investigated as an analog of hematite spherules found in Meridiani Planum on Mars to support interpretations of water-rock interactions...
2.
Yaguchi A, Yonekubo S, Maruyama I, Tatemichi S, Maruyama K, Kobayashi M
Drug Res (Stuttg) . 2016 Jan; 66(5):262-9. PMID: 26761712
Purpose: The phosphate binding capacity of PA21, a novel phosphate binder, was compared with those of other phosphate binders in vitro and in vivo. Methods: 1) For in vitro studies,...
3.
Takenouchi K, Shrestha B, Yamakuchi M, Yoshinaga N, Arimura N, Kawaguchi H, et al.
Exp Clin Endocrinol Diabetes . 2014 May; 122(5):308-15. PMID: 24839224
Pancreatic β cell-derived vascular endothelial growth factor A (VEGF-A) contributes to normal β cell function. We therefore hypothesized that non-β cell-derived VEGF-A may affect its properties in adult mice.We generated...
4.
Nishiyama R, Shinoda M, Tanabe M, Oshima G, Takano K, Miyasho T, et al.
Eur Surg Res . 2014 Jan; 51(3-4):181-90. PMID: 24434684
Background: High-mobility group box chromosomal protein 1 (HMGB1) has recently been identified as an important mediator of various kinds of acute and chronic inflammation. A method for efficiently removing HMGB1...
5.
Terasawa K, Shimada Y, Kita T, Yamamoto T, Tosa H, Tanaka N, et al.
Phytomedicine . 2012 Dec; 4(1):15-22. PMID: 23195240
In an earlier placebo-controlled study, we demonstrated that a kampo (Japanese herbal) medicine called Choto-san (Diao-Teng-San in Chinese) was effective in treating vascular dementia. To evaluate its efficacy using more...
6.
Oshima G, Shinoda M, Tanabe M, Ebinuma H, Nishiyama R, Takano K, et al.
Eur Surg Res . 2012 May; 48(3):154-62. PMID: 22585050
Background: High-mobility group box 1 (HMGB1) is a monocyte-derived late-acting inflammatory mediator, which is released in conditions such as shock, tissue injury and endotoxin-induced lethality. In this study, we determined...
7.
Yoshifuku A, Oyama K, Ibusuki A, Kawasaki M, Sakanoue M, Matsushita S, et al.
Clin Exp Dermatol . 2011 Oct; 37(3):241-4. PMID: 22007878
Reiter disease (RD) is characterized by a triad of sterile arthritis, urethritis and conjunctivitis. The conditions occur concomitantly or sequentially, and are associated with mucocutaneous features such as circinate balanitis...
8.
Hosokawa K, Ohnishi T, Kondo T, Fukasawa M, Koide T, Maruyama I, et al.
J Thromb Haemost . 2011 Aug; 9(10):2029-37. PMID: 21827607
Background And Aims: In the present study, we describe a newly developed microchip-based analytical system to evaluate white thrombus formation (WTF). Efficacies of various antithrombotic agents were compared under different...
9.
Ito T, Maruyama I
J Thromb Haemost . 2011 Jul; 9 Suppl 1:168-73. PMID: 21781252
Thrombomodulin (TM) is an endothelial anticoagulant cofactor that promotes thrombin-mediated activation of protein C. Recently, we conducted a multicentre, double-blind, randomized trial to evaluate the efficacy and safety of recombinant...
10.
Kohno M, Watanabe M, Izumi Y, Tasaka S, Kitagawa Y, Maruyama I, et al.
Thorac Cardiovasc Surg . 2011 May; 60(2):124-30. PMID: 21544787
Background: The systemic and pulmonary inflammatory response associated with pneumonectomy performed via minithoracotomy versus that after open posterolateral thoracotomy is uncertain. Methods: Groups consisting of 7 randomly assigned mice underwent...